Key result
In a rat model of HFpEF, the cardiac acetylome was more severely altered than the phosphoproteome or proteome in obese versus lean hearts.
Why the study?
Pathomechanisms of HFpEF remain elusive and specific therapy is lacking, with proteomic changes poorly understood despite metabolic risk factors such as obesity.
In a rat model of HFpEF, metabolic syndrome significantly alters the cardiac acetylome, highlighting titin stiffness and mitochondrial metabolism as potential therapeutic targets.
Answers are grounded in this paper and cite their sources.
Protein acetylation may predominate in obese HFpEF; rat data leave open human translation and therapeutic targeting.
AIMS: Despite the high prevalence of heart failure with preserved ejection fraction (HFpEF), the pathomechanisms remain elusive and specific therapy is lacking. Disease-causing factors include metabolic risk, notably obesity. However, proteomic changes in HFpEF are poorly understood, hampering therapeutic strategies. We sought to elucidate how metabolic syndrome affects cardiac protein expression, phosphorylation and acetylation in the Zucker diabetic fatty/Spontaneously hypertensive heart failure F1 (ZSF1) rat HFpEF model, and to evaluate changes regarding their potential for treatment. MAIN METHODS: ZSF1 obese and lean rats were fed a Purina diet up to the onset of HFpEF in the obese animals. We quantified the proteome, phosphoproteome and acetylome of ZSF1 obese versus lean heart tissues by mass spectrometry and singled out targets for site-specific evaluation. KEY FINDINGS: The acetylome of ZSF1 obese versus lean hearts was more severely altered (21 % of proteins changed) than the phosphoproteome (9 %) or proteome (3 %). Proteomic alterations, confirmed by immunoblotting, indicated low-grade systemic inflammation and endothelial remodeling in obese hearts, but low nitric oxide-dependent oxidative/nitrosative stress. Altered acetylation in ZSF1 obese hearts mainly affected pathways important for metabolism, energy production and mechanical function, including hypo-acetylation of mechanical proteins but hyper-acetylation of proteins regulating fatty acid metabolism. Hypo-acetylation and hypo-phosphorylation of elastic titin in ZSF1 obese hearts could explain myocardial stiffening. SIGNIFICANCE: Cardiometabolic syndrome alters posttranslational modifications, notably acetylation, in experimental HFpEF. Pathway changes implicate a HFpEF signature of low-grade inflammation, endothelial dysfunction, metabolic and mechanical impairment, and suggest titin stiffness and mitochondrial metabolism as promising therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Koser et al. (2022) studied Heart failure with preserved ejection fraction (HFpEF). Metabolic syndrome / obesity (ZSF1 obese rats) vs. ZSF1 lean rats was evaluated on Proteome, phosphoproteome, and acetylome changes in heart tissues. In a rat model of HFpEF, the cardiac acetylome was more severely altered than the phosphoproteome or proteome in obese versus lean hearts.
Synapse has enriched 10 related papers. Consider them for comparative context: